Menu
  • Join
  • Login
  • Contact
 

Search abstracts


A new anti-TB agent targeting dehydroquinate synthase

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: ZHU, Ningyu (Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences, Beijing, China)
  • Co-author(s): Ningyu Zhu: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China
    Shuyi Si: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China
  • Abstract:

    Backgrounds

    Tuberculosis, which is caused by Mycobacterium tuberculosis (M. tuberculosis), is a widespread infectious disease leading to 1.5 million deaths each year. In addition, antibiotic resistance is a growing problem for TB (tuberculosis) infections, with MDR- and XDR-TB infections being reported worldwide. Unfortunately, only two new..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses